Ravgen's Prenatal Test Patent Win Boosted To $372M
U.S. District Judge Alan Albright has agreed to enhance biotechnology company Ravgen's $272 million jury award in its patent suit against rival Labcorp over a testing method for genetic disorders, adding...To view the full article, register now.
Already a subscriber? Click here to view full article